ESR1 and neoplasm: They found the degrader 38 (Fig. 9) could induce the degradation of ERα with DC50 of 37 nM and inhibit MCF-7 cells growth with GI50 of 165 nM, and effectively inhibited ER+ MCF-7 tumor growth in a mouse xenograft model of breast cancer.